CASE STUDIES

Resolution of massive soft tissue calcifications after partial parathyroidectomy in a hemodialysed patient with chronic renal failure

 

Prof A. Wiecek
Professor of Internal Medicine and Nephrology
Head of the Department of Nephrology, Endocrinology and Metabolic Diseases
Silesian University School of Medicine
Katowice, Poland

 

A 55-years old patient with chronic renal failure due to chronic glomerulonephritis on haemodialysis for 10 years was admitted to the orthopaedic department due to the peritrochanteric fracture of the left femur. During the entire period of renal replacement therapy this patient was uncompliant with respect to a low phosphorus diet and was treated regularly with calcium carbonate (3-6 g per day) and periodically with aluminium hydroxide as phosphate binders. Seven years later severe secondary hyperparathyroidism was diagnosed (iPTH 750 pg/ml), and active vitamin D metabolites were introduced. Repeated measurements of bone mineral density showed a continuous decrease of bone mineralisation.
Twelve months before the fracture occurred, the patient started to complain of pain in the left hip. Radiological examination revealed large periarticular femoral soft tissue calcification and calcification of the vascular wall of the aorta and both iliac arteries. Administration of vitamin D metabolites were suspended and sevelamer with low calcium dialysis fluid (1,25 mmol/l) were introduced. Nevertheless, radiological examination 8 months later showed an enlargement of metastatic calcifications.

Figure 1
Figure 2


After admission to the orthopaedic department, the fractured bone was stabilised with a Wagner revision prosthesis. During the following days, the patient developed hypercalcaemia (total serum calcium 3,2 mmol/l, ionised blood calcium 2,1 mmol/l). Serum phosphorus was elevated (2,1-2,4 mmol/l). Haemodialysis sessions performed daily with low calcium dialysate (1,25 mmol/l) and intravenous bisphosphonates were ineffective to treat the high serum calcium. A month after the incidence, the Wagner revision prosthesis was removed and the fracture fragments were joined surgically with 3 proximal femoral nails.

Question 1

The treatment of hypercalcaemia was continued with oral bisphosphonates for the next 2 months but was not effective (total serum calcium 3.1 mmol/l). In spite of persistent hypercalcaemia, the plasma parathyroid hormone concentration decreased from over 1000 pg/ml to 130 pg/ml. After visualisation of 4 enlarged parathyroid glands, the patient was referred to a surgeon. Successful subtotal parathyreoidectomy was followed by normalisation of serum concentrations of calcium and phosphorus.
Twelve moths later, repeated radiological examination of the left femur revealed nearly complete disappearance of periarticular calcification; however the fracture had still not entirely healed.

Figure 3

Question 2 and 3

References:

Kuzela DC, Huffer WE, Conger JD, Winter SD, Hammond WS. Soft tissue calcification in chronic dialysis patients. Am J Pathol 1977; 86: 403-424. Pubmed Link
Andress DL. Intravenous versus oral vitamin D therapy in dialysis patients: what is the question? Am J Kidney Dis 2001; 38 (Suppl. 5): S41-44. Pubmed Link
Sabeel A., Al.-Homrany M. Complete resorption of massive soft tissue calcification in a hemodialysis patient after parathyreoidectomy. Am J Nephrol 2000; 20: 421-424. Pubmed Link
Winters JL, Kleinschmidt AG Jr, Frensilli JJ, Sutton M. Hypercalcemia complicating immobilization in the treatment of fractures. A case report. J Bone Joint Surg Am 1966; 48: 1182-1184. Pubmed Link
Levine C, Greer RB 3rd, Gordon SL. Hypercalcemia complicating fracture immobilization: a report of three cases. J Trauma 1975; 15: 70-72. Pubmed Link
Conley SB, Shackelford GD, Robson AM. Severe immobilization hypercalcemia, renal insufficiency, and calcification. Pediatrics 1979;6 3: 142-145. Pubmed Link
Bardin T. Musculoskeletal manifestations of chronic renal failure. Curr Opin Rheumatol 2003; 15: 48-54. Pubmed Link
Ziegler R. Hypercalcemic crisis. J Am Soc Nephrol 2001; 12 Suppl 17: S3-9. Pubmed Link
Sellers E, Sharma A, Rodd C. The use of pamidronate in three children with renal disease. Pediatr Nephrol 1998; 12: 778-781. Pubmed Link